Volume 6, Number 5—October 2000
Seroprevalence of Human Hantavirus Infection in the Ribeirão Preto Region of São Paulo State, Brazil
Highlight and copy the desired format.
|EID||Holmes R, Boccanera R, Figueiredo LT, Mançano SR, Pane C. Seroprevalence of Human Hantavirus Infection in the Ribeirão Preto Region of São Paulo State, Brazil. Emerg Infect Dis. 2000;6(5):560-561. https://dx.doi.org/10.3201/eid0605.000523|
|AMA||Holmes R, Boccanera R, Figueiredo LT, et al. Seroprevalence of Human Hantavirus Infection in the Ribeirão Preto Region of São Paulo State, Brazil. Emerging Infectious Diseases. 2000;6(5):560-561. doi:10.3201/eid0605.000523.|
|APA||Holmes, R., Boccanera, R., Figueiredo, L. T., Mançano, S. R., & Pane, C. (2000). Seroprevalence of Human Hantavirus Infection in the Ribeirão Preto Region of São Paulo State, Brazil. Emerging Infectious Diseases, 6(5), 560-561. https://dx.doi.org/10.3201/eid0605.000523.|
To the Editor: Hantavirus pulmonary syndrome (HPS) has been identified in the region of Ribeirão Preto, São Paulo State, Brazil, since 1993 (1-4). As of September 1999, 38 HPS cases had been reported in Brazil, 16 in the state of São Paulo (2). Between May 1998 and August 1999, the Adolfo Lutz Institute (ALI) in São Paulo city serologically confirmed five cases--three fatal--in the Ribeirão Preto region: two from Guariba, one from Jardinópolis, one from Cajuru, and one from Cassia dos Coqueiros (Luiza Teresinha Madia de Souza, ALI, pers. comm.).
Despite these reports and suspicions of additional cases, the prevalence of hantavirus infection and HPS in the region is not known. Laboratory confirmation has not been available locally, and sending serum samples to ALI for laboratory evaluation is not feasible in most cases. Thus, only presumptive diagnoses could be made until the Sin Nombre virus (SNV) enzyme-linked immunosorbent assay (ELISA) was developed.
To estimate the occurrence and distribution of human hantavirus infection, we used SNV ELISA to conduct a serologic survey of a sample of hospital patients requiring venipuncture for routine procedures. The patients came from three regional cities: Ribeirão Preto, Guariba, and Jardinópolis. Between February and June 1999, a total of 567 samples were collected: 257 from the public hospital of Guariba, 110 from the public hospital in Jardinópolis, and 200 from the General Hospital of the School of Medicine of Ribeirão Preto. When we compared our sample with the general population, the patients in the study sample were slightly older but similar in sex distribution.
Sixteen additional samples were evaluated to confirm the effectiveness of SNV ELISA in diagnosing hantavirus infection: 12 from patients in whom HPS was clinically suspected and 4 previously confirmed by ALI in the city of São Paulo between May 1998 and August 1999. Known HPS convalescent-phase plasma provided by the Centers for Disease Control and Prevention (CDC) was used as positive control. Negative controls were selected by simple random sampling from all previously negative samples.
Positive and negative recombinant SNV antigens provided by CDC were coated on microtiter plates at 1:2,000 dilution in phosphate-buffered saline overnight at 4°C and used in a standard immunoglobulin G testing format. Reverse transcriptase-polymerase chain reaction analysis of serum from two fatal cases of HPS occurring in the cities of Franca and Araraquara suggested the presence of two genetically distinct hantaviruses in the area surrounding Ribeirão Preto. Antigen prepared from local virus is not considered to be necessary for immunoassays because the local virus is not sufficiently different from other isolates to require special antigen preparation (5)
All samples were screened in duplicate on both positive and negative antigens in the assay. A sample was considered positive if two criteria were met: absorbance on the positive antigen was 25% greater than absorbance on the negative control antigen and absorbance on the positive antigen was greater than absorbance on the negative control of the plate. To confirm the diagnosis, samples satisfying these criteria were tested in duplicate along with 14 negative samples. Samples were considered positive when their subtractive absorbance was greater than the calculated mean subtractive absorbance of the 14 negative samples and three standard deviations.
From our serologic survey, the seroprevalence of human hantavirus infection was determined to be 1.23% (7/567) overall, 0.5% (1/200) in Ribeirão Preto, 0.4% (1/257)in Guariba, and 4.5% (5/110) in Jardinópolis. If one assumes the inhabitants sampled were representative, the seroprevalence provides an estimate of surviving past or recent hantavirus infections in the area. As the overall antibody prevalence of 1.23% is more than twice that observed in the U.S. populations at risk for hantavirus infection, such infections are not rare in the Ribeirão Preto region (6).
Three of the four HPS samples previously confirmed by the ALI in São Paulo tested positive by our ELISA. Of the remaining 12 suspected HPS cases assayed, three were positive. Two of these three were later confirmed as positive by the ALI (Luiza Teresinha Madia de Souza, ALI, pers. comm.) Thus, we report three previously unconfirmed HPS cases, one fatal, in the Ribeirão Preto area between May 1998 and August 1999.
Since the rodent reservoir is not known and the virus has not been isolated, rodent capture is currently being conducted in areas where human infections have been found. In addition, positive cases are being retrospectively investigated.
Thanks to Thomas Ksiazek for provision of recombinant SNV antigen and positive serum and to Robert Shope for his assistance.
The study was partially funded by a grant from the National Institutes of Health, Bethesda, Maryland, USA, and Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil.
- Figueiredo LTM, Moreli ML, Almeida VSO, Félix PR, Bruno JC, Ferreira IB, Hantavirus Pulmonary Syndrome (HPS) in Guariba, SP, Brazil. A report of 2 cases. Rev Inst Med Trop Sao Paulo. 1999;41:131–7.
- Johnson AM, de Souza LTM, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol. 1999;59:527–35.
- Ferreira MS, Nishioka SA, Santos TL, Santos RP, Santos PS, Rocha A. Hantavirus pulmonary syndrome in Brazil: clinical aspects of three new cases. Rev Inst Med Trop Sao Paulo. 2000;42:41–6.
- Da Silva MV, Vasconcelos MJ, Hidalgo NT, Veiga AP, Canzian M, Marotto PC, Hantavirus pulmonary syndrome: report of the first three cases in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 1997;39:231–4.
- Peters CJ. Emerging infections: hantavirus pulmonary syndrome in the Americas. Washington: ASM Press;1998.
- Zeitz PS, Butler JC, Cheek JE, Samuel MC, Childs JE, Shands LA, A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis. 1995;171:864–70.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 17, 2010
- Page last updated: December 17, 2010
- Page last reviewed: December 17, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)